Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Germany

European Innovation Council · Running

OptoWavePro Near natural hearing restoration through waveguide-based optical cochlear implants

Coordinator
Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen Rechts, Germany
Runs
1 April 2024 to 31 March 2027
Status
Running
EU funding
€2.5m
Total cost
€2.5m
Partners
5 organisations in 3 countries
Type
European Innovation Council
Grant agreement
101158920

What the project is doing

In the project's own words, from its summary on CORDIS.

OptoWavePro aims to develop a human prototype for an optical stimulator for optogenetic hearing restoration in individuals with profound hearing impairment. Leveraging optogenetics and biomedical engineering, we strive to restore near-natural hearing by precise optogenetic control of the auditory nerve for which we obtained preclinical proof. Our multidisciplinary team will design, fabricate, and validate the stimulator, emphasizing safety, efficacy, and regulatory compliance.

Preclinical studies will validate efficacy, reliability, and biocompatibility, to prepare clinical trials. The OptoWavePro consortium will introduce a new paradigm of integrating arrays of laser diodes, micro-lenses and polymer-based waveguides on minimal space for the optical stimulator to meet the required form factor of the optical cochlear implant. We will facilitate the upscaling of optical stimulation channels by combining custom-designed and complementary elements with lateral channel pitches of only 100 micrometers throughout the optical pathway.

Our biomedical engineering focusses on achieving efficacy and safety by housing all electronic components in a hermetically sealed titanium housing with optical feedthroughs and efficient and stable light in- and outcoupling of the waveguide array. The optical cochlear implant has the potential to revolutionize hearing restoration, merging scientific innovation with clinical impact, and transforming lives globally.

Topics

Who is involved

OrganisationCityCountryRole
Universitaetsmedizin Goettingen - Georg-August-Universitaet Goettingen - Stiftung Oeffentlichen RechtsGoettingenGermanyCoordinator
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Optogentech GmbHGottingenGermanyParticipant
Modulight OyjTampereFinlandParticipant
Societe Des Ceramiques TechniquesBazetFranceParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI